Novel 3-deoxy-3-descladinosyl-6-O-methyl erythromycin a analogues. Synthesis and in vitro activity

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 5, 1997, Pages 641-646

  Elliott, Richard L ^a,b   Pireh, Daisy ^a   Nilius, Angela M ^a   Johnson, Pauline M ^a   Flamm, Robert K ^a   Chu, Daniel T W ^a   Plattner, Jacob J ^a   Or, Yat Sun ^a  

^a ABBOTT LABORATORIES   (United States)

^b Dept 47N ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ERYTHROMYCIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 0031552163     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00078-4     Document Type: Article

References (24)

1. 1. Weisblum, B. Antimicrob. Agents Chemother. 1995, 39, 577.
2. 2. Cloutier, M. J. Amer. J. Pharm. Educ. 1995, 59, 167.
3. 3. Macrolides. Chemistry, Pharmacology and Clinical Uses; Bryskier, A. J.; Butzler, J.-P.; Neu, H. C.; Tulkens, P. M., Eds.; Arnette Blackwell: Paris, 1993.
4. 4. Hashisaki, G. T. Am. J. Otolaryngology 1995, 16, 153.
5. 5. Bryskier, A.; Labro, M. T. Presse Medicale 1994, 23, 1762.
6. 6. Lartey, P. A.; Perun, T. J. Studies in Natural Products Chemistry 1993, 13, 155.
7. 7. Chu, D. Exp. Opin. Invest. Drugs 1995, 4, 65.
8. 8. Bryskier, A.; Agouridas, G.; Chantot, J-F. Expert Opinion Of Investigational Drugs 1994, 3, 405.
9. 9. Omura, S.; Tsuzuki, K.; Sunazuka, T.; Toyota, H.; Takahashi, I.; Itoh, Z. J. Antibiot. 1985, XXXVIII, 1631.
10. 10. Burette, A.; Glupczynski, Y. Infection 1995, 23, S4.
11. 11. Konno, S.; Asano, K.; Kurokawa, M.; Ikeda, K.; Okamoto, K.; Adachi, M. International Archives of Allergy And Immunology 1994, 105, 308.
12. 12. Miyatake, H.; Suzuki, K.; Taki, F.; Satake, T. Arzneim.-Forsch. Drug Res. 1991, 41, 552.
13. 13. Takizawa, H.; Desaki, M.; Ohtoshi, T.; Kikutani, T.; Okazaki, H.; Sato, M.; Akiyama, N.; Shoji, S.; Hiramatsu, K.; Ito, K. Biochem. Biophys. Res. Comm. 1995, 210, 781.
14. 14. Agouridas, C.; Bonnefoy, A.; Chantot, J. F.; Le Martret, O.; Denis, A. (Roussel-Uclaf); EP596802-A1, May 11, 1994.
15. 15. Le Martret, O.; Agouridas, C.; Bonnefoy, A.; Chantot, J. F.; Denis, A. (Roussel-Uclaf); FR2697524-A1, May 6, 1994.
16. 16. Baker, W. R.; Clark, J.; Stephens, R. L.; Kim, K. H. J. Org. Chem. 1988, 53, 2340.
17. 17. Agouridas, C.; Benedetti, Y.; Chantot, J. F.; Denis, A.; Le Martret, O. (Roussel-Uclaf); EP676409-A1, October 11, 1995; also see; Agouridas, C.; Benedetti, Y.; Denis, A.; Le Martret, O.; Chantot, J. F. 35th Intersci. Conf. Antimicrob. Agents Chemother. 1995, Abstr. No. F157, San Francisco, Sept. 17-20.
18. 17. Agouridas, C.; Benedetti, Y.; Chantot, J. F.; Denis, A.; Le Martret, O. (Roussel-Uclaf); EP676409-A1, October 11, 1995; also see; Agouridas, C.; Benedetti, Y.; Denis, A.; Le Martret, O.; Chantot, J. F. 35th Intersci. Conf. Antimicrob. Agents Chemother. 1995, Abstr. No. F157, San Francisco, Sept. 17-20.
19. 18. Griesgraber, G.; Or, Y. S.; Chu, D. T. W.; Nilius, A. M.; Johnson, P. M.; Flamm, R. K.; Henry, R. F.; Plattner, J. J. J. Antibiot. 1996, 49, 465.
20. 19. Misawa, A.; Kahimura, M.; Kashimura, H. WO 9417088; Taisho Pharm. Co. Ltd
21. 20. 3-Deoxy analogues of Tylosin, a 16-membered macrolide, have been shown to have good antibacterial activity. See: (a) Kageyama, S.; Tsuchiya, T.; Umezawa, S.; Oritat, M. Bull. Chem. Soc. Jpn. 1992, 65, 3405;
22. (b) Kageyama, S.; Tsuchiya, T.; Umezawa, S.; Takeuchi, T. Y. J. Antibiot. 1992, 45, 144;
23. (c) Kageyama, S.; Tsuchiya, T. J. Antibiot. 1994, 47, 955.
24. 21. Elliott, R. L.; Or, Y. S.; Pireh, D.; Chu, D. US Patent Application 5827.US.Z1; Filed Nov 8th, 1995.